Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Basic Science Posters (Oncology)

  • You have access
    SPECT and optical multimodality imaging of HIF-active tumors by using an oxygen-dependent degradation protein probe with interchangeable labeling system
    Izumi Umeda, Yuu Kakishima, Sadaaki Kimura, Masayuki Yamaguchi, Takahiro Kuchimaru, Shinae Kizaka-Kondoh, Akinori Yanaka and Hirofumi Fujii
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1723;
  • You have access
    Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3’-deoxy-3’-[18F]fluorothymidine using preclinical tumor models
    Seung Jin Lee, Hye Young Kang, Seog Young Kim, Jin Hwa Chung, Seung Jun Oh, Jin-Sook Ryu, Jong Soon Kang, Hwan Mook Kim, Myung-Hwa Kim and Dae Hyuk Moon
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1677;
  • You have access
    Comparison between 68Ga-BZH3 and 68Ga-RGD studies in an experimental nude rat model with a neuroendocrine tumor cell line
    Caixia Cheng, Leyun Pan, Antonia Dimitrakopoulou-Strauss, Uwe Haberkorn and Ludwig Strauss
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1715;
  • You have access
    Intratumor non-uniform and mismatch-pattern distribution of 18F-FLT and 18F-FDG activity in human non-small cell lung cancer in mice by micro PET and histological correlates
    Xiao-Feng Li, Tao Huang, Junling Li, Huaiyu Zheng, A. Civelek, Gregory Postel and Chin Ng
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1695;
  • You have access
    Correlation of the Ga-68-Bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET)
    Ludwig Strauss, Dirk Koczan, Marcel Seiz, Jochen Tuettenberg, Uwe Haberkorn and Antonia Dimitrakopoulou-Strauss
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1708;
  • You have access
    Evaluation of 18F-FLT and 123I-ICdR as radioprobes for monitoring the therapeutic efficacy of lipo-dox in a HepG2 hepatoma mouse mode
    Lin-Shan Chou, Chun-Yi Wu, Pei-Chia Chan, Chung-Hsien Ho, Chuan-Lin Chen, Ren-Shyan Liu, Chih-Chieh Shen, Wuu-Jyh Lin, Ming-Hsien Lin and Hsin-Ell Wang
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1716;
  • You have access
    Study of glioblastoma multiforme metastatic and invasive mechanism by polycistronic imaging probe in tumor implanted animal model
    Liang-ting Lin, Shih-Hwa Chiou, Chiung-Tong Chen and Yi-Jang Lee
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1709;
  • You have access
    Salivary protection after radioiodine therapy using NIS interfering siRNA in rat model
    Ilhan Lim, Hyewon Youn, Hyo Sang Lee, Yong-il Kim, Chan Joo Yeom, June-Key Chung, Myung Chul Lee and Dong Soo Lee
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1693;
  • You have access
    EGFR tyrosine kinase inhibitor ZD1839 mediates significantly increased tumor uptake of hEGF in nude mouse models
    Zhaofei Liu, Peng He, Xujie Liu and Fan Wang
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1706;
  • You have access
    Preclinical comparison of BB2r antagonist targeting of prostate cancer
    Tammy Rold, Ashley Szczodroski, Gary Sieckman, Rolando Breier, Wynn Volkert and Timothy Hoffman
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1676;

Pages

  • Previous
  • Next
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire